Difference between revisions of "Mirtazapine-nortriptyline"

From Psychiatrienet
Jump to: navigation, search
Line 9: Line 9:
 
* '''Day 1:''' simultaneously start administration of nortriptyline in a dosage of 50 mg/day.  
 
* '''Day 1:''' simultaneously start administration of nortriptyline in a dosage of 50 mg/day.  
 
* '''Day 8:''' stop administration of mirtazapine and continue administration of nortriptyline. If necessary, increase dosage of nortriptyline.
 
* '''Day 8:''' stop administration of mirtazapine and continue administration of nortriptyline. If necessary, increase dosage of nortriptyline.
* "Start low, go slow" is not required, but caution is necessary.}}
+
* "Start low, go slow" is not required, but caution is necessary.
  
 
| info =
 
| info =
 
{{review}}
 
{{review}}
 +
}}

Revision as of 14:26, 5 October 2015

Mirtazapine
Type Antidepressant
Group other
links
Medscape Mirtazapine
PubChem 4205
PubMed Mirtazapine
Kompas (Dutch) Mirtazapine
Wikipedia Mirtazapine
Nortriptyline
Type Antidepressant
Group TCA
links
Medscape Nortriptyline
PubChem 4543
PubMed Nortriptyline
Kompas (Dutch) Nortriptyline
Wikipedia Nortriptyline

Switch medication from mirtazapine to nortriptyline.[1] [2]

Nietinrijdenbord.png Stop mirtazapine
  • Before day 1: gradually reduce dosage of mirtazapine to a maximum of 30 mg/ day.
  • Day 1: reduce a dosage of 30 mg/day to 15 mg/day.
Eenrichtingbord.png Start nortriptyline

No wash-out period is needed.

  • Day 1: simultaneously start administration of nortriptyline in a dosage of 50 mg/day.
  • Day 8: stop administration of mirtazapine and continue administration of nortriptyline. If necessary, increase dosage of nortriptyline.
  • "Start low, go slow" is not required, but caution is necessary.
Infobord.png More information
  • This switch is currently being reviewed.
  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.